64170-55-4 Usage
Uses
Used in Pharmaceutical Industry:
4-(5-METHYL-1H-TETRAZOL-1-YL)ANILINE is used as a building block for the development of pharmaceutical compounds due to its ability to contribute to the creation of drugs with diverse biological activities. The tetrazole ring in its structure is particularly advantageous for designing drugs with antimicrobial, antiviral, and antitumor properties, making it a valuable asset in medicinal chemistry.
Used in Chemical Industry:
In the chemical industry, 4-(5-METHYL-1H-TETRAZOL-1-YL)ANILINE is utilized as a versatile precursor for synthesizing a variety of heterocyclic compounds and polymers. Its presence of the aniline group allows for the formation of complex organic structures that are essential in the development of new materials and chemical products.
Used in Organic Synthesis:
4-(5-METHYL-1H-TETRAZOL-1-YL)ANILINE is employed as a key intermediate in organic synthesis, where its unique structure facilitates the formation of complex organic molecules. Its role in this process is crucial for the production of specialty chemicals and advanced materials.
Used in Dye Production:
4-(5-METHYL-1H-TETRAZOL-1-YL)ANILINE is used as a component in the production of dyes, capitalizing on its chemical properties to create a range of colorants for various applications, including textiles, plastics, and printing inks.
Check Digit Verification of cas no
The CAS Registry Mumber 64170-55-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,1,7 and 0 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 64170-55:
(7*6)+(6*4)+(5*1)+(4*7)+(3*0)+(2*5)+(1*5)=114
114 % 10 = 4
So 64170-55-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H9N5/c1-6-10-11-12-13(6)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3
64170-55-4Relevant academic research and scientific papers
SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
-
Page/Page column 76, (2009/12/02)
Substituted cyclopropyl compounds of formula (I) are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
